[HTML][HTML] Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era
A Khurana, R Mwangi, SM Ansell, TM Habermann… - Blood cancer …, 2021 - nature.com
Immediate treatment for asymptomatic, low-tumor burden follicular lymphoma (FL) has not
shown an overall survival benefit over “watch and wait”(W/W) strategy. We estimated …
shown an overall survival benefit over “watch and wait”(W/W) strategy. We estimated …
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era
A Khurana, R Mwangi, SM Ansell… - Blood cancer journal …, 2021 - iro.uiowa.edu
Immediate treatment for asymptomatic, low-tumor burden follicular lymphoma (FL) has not
shown an overall survival benefit over" watch and wait"(W/W) strategy. We estimated …
shown an overall survival benefit over" watch and wait"(W/W) strategy. We estimated …
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era
A Khurana, R Mwangi, SM Ansell… - Blood cancer …, 2021 - mayoclinic.elsevierpure.com
Immediate treatment for asymptomatic, low-tumor burden follicular lymphoma (FL) has not
shown an overall survival benefit over “watch and wait”(W/W) strategy. We estimated …
shown an overall survival benefit over “watch and wait”(W/W) strategy. We estimated …
[HTML][HTML] Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era
A Khurana, R Mwangi, SM Ansell… - Blood Cancer …, 2021 - ncbi.nlm.nih.gov
Immediate treatment for asymptomatic, low-tumor burden follicular lymphoma (FL) has not
shown an overall survival benefit over “watch and wait”(W/W) strategy. We estimated …
shown an overall survival benefit over “watch and wait”(W/W) strategy. We estimated …
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.
A Khurana, R Mwangi, SM Ansell… - Blood Cancer …, 2021 - europepmc.org
Immediate treatment for asymptomatic, low-tumor burden follicular lymphoma (FL) has not
shown an overall survival benefit over “watch and wait”(W/W) strategy. We estimated …
shown an overall survival benefit over “watch and wait”(W/W) strategy. We estimated …
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era
A Khurana, R Mwangi, SM Ansell… - Blood cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Immediate treatment for asymptomatic, low-tumor burden follicular lymphoma (FL) has not
shown an overall survival benefit over" watch and wait"(W/W) strategy. We estimated …
shown an overall survival benefit over" watch and wait"(W/W) strategy. We estimated …
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.
A Khurana, R Mwangi, SM Ansell… - Blood Cancer …, 2021 - search.ebscohost.com
Immediate treatment for asymptomatic, low-tumor burden follicular lymphoma (FL) has not
shown an overall survival benefit over" watch and wait"(W/W) strategy. We estimated …
shown an overall survival benefit over" watch and wait"(W/W) strategy. We estimated …
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era
A Khurana, R Mwangi, SM Ansell… - Blood Cancer …, 2021 - search.proquest.com
Immediate treatment for asymptomatic, low-tumor burden follicular lymphoma (FL) has not
shown an overall survival benefit over “watch and wait”(W/W) strategy. We estimated …
shown an overall survival benefit over “watch and wait”(W/W) strategy. We estimated …
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.
A Khurana, R Mwangi, SM Ansell… - Blood Cancer …, 2021 - europepmc.org
Immediate treatment for asymptomatic, low-tumor burden follicular lymphoma (FL) has not
shown an overall survival benefit over “watch and wait”(W/W) strategy. We estimated …
shown an overall survival benefit over “watch and wait”(W/W) strategy. We estimated …